KAM1403 Gel

· Kamedis Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KAM1403 Gel, covering 2014-01-31 to 2014-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis [Phase 2]